KennethReedShroyerMDPhD
Pathology • Stony Brook, NYCytopathology, Anatomic Pathology, Clinical Pathology, Surgical Pathology
Professor and Chair Department of Pathology School of Medicine Stony Brook University
Dr. Shroyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Nicolls Rd.
BST9k, Rm 140
Stony Brook, NY 11794Phone+1 531-444-3000
Summary
- Dr. Kenneth Shroyer is a pathologist in Stony Brook, NY and is affiliated with Stony Brook University Hospital. He received his medical degree from University of Colorado School of Medicine and has been in practice 30 years. He specializes in cytopathology, anatomic pathology, clinical pathology, and surgical pathology and is experienced in cytopathology, surgical pathology, biomedical research, and pathology.
Education & Training
University of ColoradoResidency, Pathology-Anatomic and Clinical, 1987 - 1991- University of Colorado School of Medicine Anschutz Medical CampusClass of 1987
Certifications & Licensure
NY State Medical License 2007 - 2026
CO State Medical License 1988 - 2009- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
Clinical Trials
- Extralevator Versus Standard Abdominoperineal Resection For Rectal Adenocarcinoma Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- Keratin 17 and A2ML1 are negative prognostic biomarkers in non-small cell lung cancer.Sruthi Babu, Michael Horowitz, Lyanne A Delgado-Coka, Lucia Roa-Peña, Ali Akalin
Pathology, Research and Practice. 2024-11-01 - 1 citationsPerioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.Michael Cecchini, Ronald R Salem, Marie Robert, Suzanne Czerniak, Ondrej Blaha
JAMA Oncology. 2024-08-01 - 1 citationsKeratin 17 modulates the immune topography of pancreatic cancer.Lyanne Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, Lucia Roa-Peña, Cindy V Leiton
Journal of Translational Medicine. 2024-05-10
Journal Articles
- Keratin 17 Is a Sensitive and Specific Biomarker of Urothelial NeoplasiaDaniel C Mockler, Shahram S Gholami, Kenneth R Shroyer, Richard Moffitt, Nam W Kim, Nature
Press Mentions
Urine Test Detects New or Returning Bladder CancerJune 9th, 2021- New Non-Invasive Test Can Detect Bladder CancerJune 4th, 2021
Meet Our 2018 Research Grantees: Translational AwardsJuly 18th, 2018- Join now to see all
Grant Support
- P16 And HPV In Low-Grade Cervical Cytologic SpecimensNational Cancer Institute2007
- P16 And HPV In Low-Grade Cervical Cytologic SpecimensNational Cancer Institute2005–2007
- P16 And HPV In Low-Grade Cervical Cytologic SpecimensNational Cancer Institute2004
- Telomerase And HPV In PAP Smears And Cervical BiopsiesNational Cancer Institute1999–2001
- Clonality In Endometrium And OvaryNational Cancer Institute1993
Research History
- Principal InvestigatorResearch in my lab has included the discovery and validation of diagnostic, prognostic, and predictive cancer biomarkers, including X-chromosome inactivation, telomerase, p16INK4a, and B7-H4, impacting concepts on the interaction of tumor cells with the inflammatory microenvironment.1991 - Present
Professional Memberships
- Member
- United States and Canadian Academy of PathologyMember
- American Society for CytopathologyMember
- College of American PathologistsMember
- Association of Pathology ChairsMember
Industry Relationships
- Scientific Advisory Board Member, KDx Inc.2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
